Research programme: vacuolar protein sorting-associated protein 4A inhibitors - Calithera Biosciences
Latest Information Update: 25 Apr 2023
At a glance
- Originator Calithera Biosciences
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer